Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Pharmaceutical Research|July 19, 2014
Inflation of the type I error: investigations on regulatory recommendations for bioequivalence of highly variable drugsMeinolf Wonnemann, Cornelia Frömke, Armin Koch
Research Synthesis Methods|June 15, 2022
A semiparametric approach for meta-analysis of diagnostic accuracy studies with multiple cut-offsCornelia Frömke, Mathia Kirstein, Antonia Zapf
Archives of Gynecology and Obstetrics|June 19, 2013
The timing of amniotomy, oxytocin and neuraxial analgesia and its association with labour duration and mode of birthMechthild M Gross, Cornelia Frömke, Hartmut Hecker
BMC Bioinformatics|January 29, 2008
Nonparametric relevance-shifted multiple testing procedures for the analysis of high-dimensional multivariate data with small sample sizesCornelia Frömke, Ludwig A Hothorn, Siegfried Kropf
BMC Genomics|December 8, 2014
Identification of a lineage specific zinc responsive genomic island in Mycobacterium avium ssp. paratuberculosisElke Eckelt, Michael Jarek, Cornelia Frömke, et al.
Midwifery|December 15, 2010
The timing of interventions during labour: descriptive results of a longitudinal studyAntje Petersen, Gertrud M Ayerle, Cornelia Frömke, et al.
Plos One|April 25, 2015
Recommendation for a Standardised Method of Broth Microdilution Susceptibility Testing for Porcine Bordetella bronchisepticaSandra Prüller, Cornelia Frömke, Heike Kaspar, et al.
Biometrical Journal. Biometrische Zeitschrift|September 27, 2024
Meta-Analysis of Diagnostic Accuracy Studies With Multiple Thresholds: Comparison of Approaches in a Simulation StudyAntonia Zapf, Cornelia Frömke, Juliane Hardt, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 10, 2019
[Ethical consideration of studies involving human subjects outside the regulatory framework: not mandatory, but of high relevance]Iris Pigeot, Ronja Foraita, Cornelia Frömke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2010
In vitro experimental (211)At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicinThorsten Petrich, Zekiye Korkmaz, Doris Krull, et al.
Pageof 4